Andere Sprachen Cathay Biotech Inc.

Aktien

688065

CNE100004447

688065

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
51.3 ^CNY	+4.35%		+26.01%	-6.69%

29.04.	Cathay Biotech Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
15.04.	Cathay Biotech's Q1 Gewinn steigt um bis zu 100%, Umsatz steigt um 43%; Aktien steigen um 6%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	15.04.
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	02.04.
Cathay Biotech's 2023 Profit Drops 34% as Revenue Falls 13%	26.02.
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
Cathay Biotech Inc. and 3P.Com Co. Limited Signs Joint Venture Agreement to Propel Sustainable Composite Innovations	08.02.
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	03.01.
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30.10.23
HBM confirme sa perte nette au premier semestre 2022/23	16.10.23
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	10.10.23
HBM Healthcare anticipe une perte semestrielle de 70 millions	02.10.23
Cathay Biotech Inc.(XSSC:688065) added to S&P Global BMI Index	18.09.23
Cathay Biotech Inc.(XSSC:688065) added to FTSE All-World Index	18.09.23
Cathay Biotech Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	17.08.23
Cathay Biotech Inc. authorizes a Buyback Plan.	17.08.23
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	03.08.23
Cathay Biotech Forms Business Cooperation Agreement	27.06.23
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	26.06.23
Cathay Biotech Inc. announced that it expects to receive CNY 6.599999958 billion in funding	25.06.23
HBM Healthcare Investments a creusé ses pertes en 2022/23	12.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cathay Biotech Inc.

Aktien

688065

CNE100004447

688065

Andere Sprachen

Filter